(Credit: © Vitalii Vodolazskyi - stock.adobe.com)
In a Nutshell
- Researchers created injectable capsules containing living cells that produce leptin, a natural hormone, which helped animals adjust their internal clocks to a new light schedule faster.
- Monkeys that received the leptin capsules showed no signs of harmful side effects, and after a forward schedule shift specifically, a measure of deep-sleep brain activity (slow-wave energy during the first half of the night) increased rather than worsened on the second and third nights following the shift.
- Unlike melatonin or timed light exposure, the treatment does not require precisely scheduled doses, potentially making it more practical for real-world use.
Anyone who has crossed multiple time zones knows the misery that follows: the 3 a.m. hunger pangs, the midday exhaustion, the foggy brain that refuses to cooperate. For shift workers, that same biological confusion is a near-permanent state of existence. Now, researchers from Rice University and Northwestern University may have found an unlikely solution hiding inside a hormone the body already makes naturally.
In a study published in the journal Advanced Science, scientists engineered tiny capsules packed with living cells designed to pump out leptin, a hormone produced by fat tissue that helps regulate appetite and metabolism. When injected under the skin of both mice and monkeys, these miniature “leptin factories” helped the animals sync their internal body clocks to a new light schedule significantly faster than animals that did not receive them. In monkeys, the treatment showed no harmful effects on sleep, and after a schedule shift forward, one key measure of deep sleep actually increased.
Human biology follows an internal 24-hour clock that governs when people feel sleepy, hungry, alert, or sluggish. When that clock falls out of sync with the outside world, the consequences go well beyond grogginess. Long-term clock disruption has been linked to obesity, Type 2 diabetes, heart disease, and depression. That makes faster adjustment potentially important for the millions of people, from flight crews to emergency room nurses, whose schedules regularly collide with their biology.
What Are These Leptin Factories, and How Do They Work?
Leptin is a hormone the body already produces, mainly from fat tissue, and it naturally rises and falls in a daily rhythm. Previous research had shown that leptin plays some role in the body’s internal timekeeping, but simply injecting the hormone into animals failed to shift their clocks on its own. Leptin also breaks down quickly in the body, lasting only about 40 minutes in mice, making it difficult to use as a sustained treatment.
To get around those hurdles, the research team engineered human retinal pigment epithelium cells to continuously produce leptin, then sealed them inside tiny beads made from alginate. Each capsule measured about 300 micrometers across, roughly three times the width of a human hair, and was injected under the skin. The capsules are designed with tiny pores sized to allow leptin and nutrients to diffuse through freely while remaining too small for immune cells to enter, helping shield the cells inside from direct contact with the immune system.
After encapsulation, the cells remained more than 93% alive and continued producing leptin at a steady rate over 24 hours. When injected into mice, leptin from the capsules remained detectable in the blood for 48 hours, far longer than the roughly 40-minute half-life of a simple hormone injection. A second round of injections given two weeks after the first produced the same results, showing the system could be reused without losing effectiveness.
Faster Clock Resets in Mice and Monkeys
To test whether the leptin factories actually helped, researchers shifted the light schedule for groups of mice, mimicking what happens when a person flies across time zones or starts a new night shift. Mice that received a control injection with no active ingredient took an average of about three days to adjust their activity patterns after a four-hour schedule delay. Mice that received the leptin capsules adjusted in roughly 2.3 days, a statistically meaningful difference. A similar pattern held when the clock was pushed forward, comparable to flying east across several time zones.
Because results in mice do not always carry over to people, the team then tested the capsules in cynomolgus macaques, a species of monkey whose daily rhythm of sleep and waking closely mirrors that of humans. Unlike mice, which are nocturnal, these monkeys are active during the day, making them a far better stand-in for studying human jet lag.
A small group of monkeys received injections of the leptin capsules, then had their light schedules shifted by six hours, either forward or backward. Researchers tracked sleep patterns, heart rates, and body temperatures to measure how quickly each monkey’s biology aligned with the new schedule. Animals that received the leptin capsules adjusted significantly faster to both types of schedule shifts, reducing the time needed for entrainment by approximately one day, with no demonstrable adverse effects observed during monitoring.
Blood tests and physical monitoring over 14 days showed no meaningful signs of harm. Kidney and liver markers stayed within normal ranges, body weight remained stable, and any minor fluctuations in lab values resolved on their own.
The Surprising Sleep Finding
One of the more unexpected results came from the sleep analysis. Researchers monitored the monkeys’ brain activity during sleep and had the recordings scored by both a trained specialist and a machine-learning system. After a schedule advance, monkeys that received the leptin capsules showed increases in slow-wave sleep energy, the deepest and most restorative phase of sleep, during the first half of the night on the second and third days after the injection.
On this point, the paper is specific: the treatment had no demonstrable adverse effects on sleep overall, and slow-wave energy increased after a phase advance. Researchers noted this finding is supported by prior work showing leptin affects this phase of sleep.
These capsules also appear to be naturally short-lived. Capsules removed from injection sites 14 days after implantation contained few living cells, and animals tracked over a year showed no lasting weight changes. That built-in fading could actually be a feature: the capsules are designed to stop producing leptin after their purpose is served, rather than running indefinitely.
A New Tool for Shift Workers, Not Just Jet-Lagged Travelers
Chronic disruption of the body’s internal clock is far more than an inconvenience. Shift workers, a group that includes a large share of healthcare workers, truck drivers, factory employees, and first responders, face elevated risks of metabolic disease, heart problems, and mental health conditions tied at least in part to the persistent mismatch between their internal clocks and the outside world. Current tools to help, including carefully timed light exposure, melatonin at specific hours, and scheduled meals, all demand strict timing that is often impractical for the very people who need it most.
Researchers are candid that the treatment is still at an early, preclinical stage, and significant questions remain before it could be tested in people. How exactly leptin speeds up clock adjustment is not yet understood. It may be influencing the brain’s response to light, or it may be working indirectly by altering other metabolic signals. The paper states plainly that the mechanism by which leptin speeds entrainment remains unclear. Long-term safety studies in animals have not yet been completed, and the researchers call for further work before any move toward human testing.
Still, this proof-of-concept approach points to a new angle on a problem that has resisted easy fixes. A sustained, low-level leptin signal that works without precisely timed doses, delivered through capsules that appear to fade naturally, offers something the current options do not. If future research confirms these effects in humans, it could eventually offer a new option for the many people whose work or travel routinely pushes their biology out of sync.
Paper Notes
Limitations
Researchers acknowledge several important limitations. First, the precise biological mechanism by which leptin speeds up clock adjustment is not understood, and the paper does not attempt to identify it. Leptin may be working indirectly through behavioral changes, other metabolic factors, or some combination of pathways. Second, the nonhuman primate portion of the study involved a small number of animals, and expanded studies with larger groups would be needed to draw firmer conclusions. Third, while the capsules were well-tolerated in the short term, long-term safety data in large animal models has not yet been collected, and the authors specifically call for long-term safety studies before any consideration of clinical translation. Fourth, the researchers note that the leptin increase produced by the capsules is more than an order of magnitude lower than typical circulating leptin levels in healthy adult humans, and the reason this modest increase appears effective is not yet fully explained.
Funding and Disclosures
According to the paper, this study was supported by the 711 Human Performance Wing (HPW) and the Defense Advanced Research Projects Agency (DARPA) under agreement number FA8650-21-1-7119. The authors declare no conflicts of interest. One of the co-authors is affiliated with CellTrans Inc., Chicago, Illinois, and another with the University of Zurich’s Department of Visceral and Transplant Surgery, as noted in the author affiliations.
Publication Details
Paper Title: “Encapsulated Leptin-Producing Cells Facilitate Entrainment of Circadian Rhythms in Rodents and Nonhuman Primates”
Authors: Samantha T. Fleury, Xuanyi Lin, Peter D. Rios, Christopher Olker, Eun Joo Song, Alejandra Cobos Perez, Cody Fell, Daisy Lopez, Ira Joshi, Hafsa Nasir, Cecelia Curtis, Danna Muringi, Kaiyuan Wang, José Oberholzer, Fred W. Turek, Isaac B. Hilton, Jonathan Rivnay, Martha Hotz Vitaterna, and Omid Veiseh
Institutions: Rice University (Houston, Texas); Northwestern University (Evanston, Illinois); CellTrans Inc. (Chicago, Illinois); University of Zurich (Zürich, Switzerland); University of Illinois at Chicago (nonhuman primate studies)
Journal: Advanced Science
DOI: 10.1002/advs.77191
Published: 2026 (Received February 17, 2026; Accepted June 30, 2026)







